Denali Therapeutics DNLI
NASDAQ DNLI
$20.66 -0.15 (-0.72%)
As of: Sep 30, 2026 · 10:25 AM EDT

Denali Therapeutics (DNLI) Capital Expenditures (2017 - 2026)

Updated

Denali Therapeutics (DNLI) reported Capital Expenditures of $805,000 for Q2 2026, down 81.2% from $4.28 million a year earlier and down 67.4% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Capital Expenditures (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Denali Therapeutics' Capital Expenditures came in at $3.42 million, down 81.4% year-over-year; for FY2025, it was $9.5 million, down 40.3% from FY2024.

  • Capital Expenditures has a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $15.91 million in FY2024 (+23.0%), $12.94 million in FY2023 (-27.4%), $17.83 million in FY2022 (+109.8%) and $8.5 million in FY2021 (+174.6%).
  • Five-year quarterly Capital Expenditures spans a low of -$1.38 million in Q3 2025 and a high of $6.05 million in Q3 2022.
  • Year over year, Capital Expenditures has now declined in each of the last three quarters, with growth averaging 19.8% over the last seven quarters.
  • The high point for year-over-year Capital Expenditures in five years was Q2 2022 (growth of 274.7%); the low point was Q2 2026 (a decline of 81.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.47 million (Q1 2026), $1.52 million (Q4 2025) and -$1.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Denali Therapeutics 3.35 Bn 3.35 Bn 3.51 Mn 805,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 805,000.00
Mar 31, 2026 2.47 Mn
Dec 31, 2025 1.52 Mn
Sep 30, 2025 -1.38 Mn
Jun 30, 2025 4.28 Mn
Mar 31, 2025 5.08 Mn
Dec 31, 2024 5.09 Mn
Sep 30, 2024 3.88 Mn
Jun 30, 2024 4.79 Mn
Mar 31, 2024 2.15 Mn
Dec 31, 2023 2.24 Mn
Sep 30, 2023 2.07 Mn
Jun 30, 2023 5.85 Mn
Mar 31, 2023 2.79 Mn
Dec 31, 2022 4.85 Mn
Sep 30, 2022 6.05 Mn
Jun 30, 2022 2.89 Mn
Mar 31, 2022 4.04 Mn
Dec 31, 2021 3.05 Mn
Sep 30, 2021 1.88 Mn
API Access

Denali Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DNLI&period=max&api_key=YOUR_API_KEY